Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.80 |
| ▸ | MEN1 | O00255 | 4/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.80 |
| ▸ | MAPT | P10636 | 4/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.80 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.80 |
| ▸ | RECQL | P46063 | 2/20 | 0.80 |
| ▸ | SOST | Q9BQB4 | 2/20 | 0.80 |
| ▸ | POLB | P06746 | 2/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.80 |
| ▸ | GAA | P10253 | 2/20 | 0.80 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.80 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.74 |
| ▸ | APP | P05067 | 1/20 | 0.74 |
| ▸ | XDH | P47989 | 1/20 | 0.66 |
| ▸ | CBS | P35520 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydrokaempferol SCHEMBL31026899 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL3437565 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL29454736 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL13354175 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL39319 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL29367287 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL3438673 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL31547241 | 0.93 | MAPT (0.70) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Pinobaksin SCHEMBL14461145 | 0.91 | MAPT (0.75) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Pinobaksin SCHEMBL1045054 | 0.91 | MAPT (0.75) | CYP3A4MEN1KMT2AMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4627099-A2 | PROCESS FOR MAKING FLAVANONE DERIVATIVES | Firmenich SA (CH) | 2025-10-08 | — | — | EP | claimed |
| US-20240390445-A1 | METHOD OF TREATING CANCER | Native Ingredients And Health Research Organisation Pty Ltd (AU) | 2024-11-28 | — | — | US | claimed |
| EP-4408196-A1 | A METHOD OF TREATING CANCER | Native Ingredients And Health Research Organisation Pty Ltd (AU) | 2024-08-07 | — | — | EP | claimed |
| WO-2024115469-A2 | PROCESS FOR MAKING FLAVANONE DERIVATIVES | FIRMENICH SA (CH) | 2024-06-06 | — | — | WO | claimed |
| US-20230233513-A1 | TAXIFOLIN FORMULATION COMPRISING THIAMINE | EVANIUM HEALTHCARE GMBH (DE) | 2023-07-27 | — | — | US | claimed |
| WO-2023049970-A1 | A METHOD OF TREATING CANCER | Native Ingredients And Health Research Organisation Pty Ltd (AU) | 2023-04-06 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| EP-4135656-A1 | TAXIFOLIN FORMULATION COMPRISING THIAMINE | Evanium Healthcare GmbH (DE) | 2023-02-22 | — | — | EP | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20220088199-A1 | METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION | SACHEM, INC. | 2022-03-24 | — | — | US | claimed |
| EP-2572713-A1 | Extracts and isolated flavonoids from Euphorbia cuneata useful as anti-ulcer agents | King Saud University (SA) | 2013-03-27 | — | — | EP | claimed |
| CN-102459215-A | 3- (4-aminophenyl) -2-furancarboxylic acid derivatives and pharmaceutically acceptable salts thereof | DAINIPPON SUMITOMO PHARMA CO | 2012-05-16 | — | — | CN | claimed |
| EP-1395539-B1 | A METHOD FOR ISOLATING PHENOLIC SUBSTANCES OR JUVABIONES FROM WOOD COMPRISING KNOTWOOD | ARBONOVA AB OY (FI) | 2009-04-22 | — | — | EP | claimed |
| CN-101336978-A | Extraction method of total flavone of Hovenia dulcisThunb | UNIV NORTHWEST SCI TECH AGRI (CN) | 2009-01-07 | — | — | CN | claimed |
| CN-1553887-A | Method for separating phenolic substances or juvabiones from wood containing nodular wood | �����ᡤ����ķ��ķ | 2004-12-08 | — | — | CN | claimed |
| US-20040199032-A1 | Method for isolating phenolic substances or javabiones from wood comprising knotwood | HOLMBOM BJARNE (FI) | 2004-10-07 | — | — | US | claimed |
| EP-1395539-A1 | A METHOD FOR ISOLATING PHENOLIC SUBSTANCES OR JUVABIONES FROM WOOD COMPRISING KNOTWOOD | Holmbom, Bjarne (FI) | 2004-03-10 | — | — | EP | claimed |
| WO-2002098830-A1 | A METHOD FOR ISOLATING PHENOLIC SUBSTANCES OR JUVABIONES FROM WOOD COMPRISING KNOTWOOD | HOLMBOM BJARNE (FI) | 2002-12-12 | — | — | WO | claimed |
| EP-0719554-A1 | Chondroprotective flavonoids | Kureha Chemical Industry Co., Ltd. (JP) | 1996-07-03 | — | — | EP | claimed |
| EP-0633022-A2 | Chondroprotective flavones | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | CYP3A4 3571/4885MEN1 1711/4885KMT2A 4742/4885 |
| US-20220088199-A1 | METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION | GK, ABHD10, CBR3 | CYP3A4 308/4885MEN1 3660/4885KMT2A 2923/4885 |
| US-20230233513-A1 | TAXIFOLIN FORMULATION COMPRISING THIAMINE | SLC19A2, TTPA, FPGS | CYP3A4 1472/4885MEN1 644/4885KMT2A 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.